BRAINTREE, Mass., Aug. 7, 2018 /PRNewswire/-- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first fiscal quarter ended June 30, 2018 are available on its Investor relations website.
The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on August 7, 2018. The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9513 Conference ID required for access: 6164607.
A live webcast of the call can be accessed on Haemonetics' investor relations website.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.